SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form S-8 - Securities to be offered to employees in employee benefit plans:
SEC Accession No. 0001213900-24-030808
Filing Date
2024-04-05
Accepted
2024-04-05 16:05:53
Documents
5
Effectiveness Date
2024-04-05

Document Format Files

Seq Description Document Type Size
1 REGISTRATION STATEMENT ea0203323-s8_virpaxpharma.htm S-8 72883
2 LEGAL OPINION OF BLANK ROME LLP ea020332301ex5-1_virpaxphar.htm EX-5.1 7571
3 CONSENT OF EISNERAMPER LLP, INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM ea020332301ex23-1_virpaxphar.htm EX-23.1 2262
4 FILING FEE TABLE ea020332301ex-fee_virpaxphar.htm EX-FILING FEES 14542
5 GRAPHIC ex5-1_001.jpg GRAPHIC 6571
  Complete submission text file 0001213900-24-030808.txt   107592
Mailing Address 1055 WESTLAKES DRIVE, SUITE 300 BERWYN PA 19312
Business Address 1055 WESTLAKES DRIVE, SUITE 300 BERWYN PA 19312 610-727-4597
Virpax Pharmaceuticals, Inc. (Filer) CIK: 0001708331 (see all company filings)

IRS No.: 821510982 | State of Incorp.: DE | Fiscal Year End: 1231
Type: S-8 | Act: 33 | File No.: 333-278522 | Film No.: 24826489
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)